NCT05716880View on ClinicalTrials.gov

Ketoanalogues for Muscle Mass Loss in Nephrotic Syndrome

PHASE3RecruitingINTERVENTIONAL
Enrollment

150

Participants

Timeline

Start Date

January 3, 2023

Primary Completion Date

February 28, 2027

Study Completion Date

August 31, 2027

Conditions
Nephrotic Syndrome
Interventions
DRUG

Ketosteril

Daily dose = 1 tabl / 5 kg of ideal body weight

OTHER

Medium Protein Diet (MPD)

MPD: daily protein intake of 0.8-1.0 g/kg of ideal body weight + up to 5 g based on daily proteinuria

Trial Locations (1)

04-141

RECRUITING

Department of Internal Diseases, Nephrology and Dialysis, Military Institute of Medicine - National Research Institute, Warsaw

All Listed Sponsors
collaborator

Medical University of Lodz

OTHER

collaborator

Medical University of Warsaw

OTHER

lead

Military Institute od Medicine National Research Institute

OTHER